Oncology Insights Reports

Oncology Insights

TRM Oncology produces Oncology Insight reports, derived from a series of closed-door roundtable meetings designed to understand the current marketplace and how emerging research will affect therapeutic decision-making, ongoing clinical trials, the development of new compounds, and future treatment paradigms.

Our CASES and EPIC reports provide a look into the current landscape of various tumor types from the perspective of both oncology experts and community oncologists.

Request Information red

EPIC Reports


Our state-of-the-art EPIC (Emerging Paradigms in Care) reports provide deep insights into a variety of disease areas. EPIC reports, created from a series of multidisciplinary meetings, are designed to facilitate nonbiased scientific interchange and discussion among leading experts in the field. Each closed-door, invitation-only EPIC meeting features 12 to 15 expert faculty. While each program is a TRM Oncology event, meeting summaries are available for purchase.

EPIC reports provide expert knowledge on the most recent developments in a variety of disease areas. They give an overview of each tumor type / pathway including updates on
Current and future landscape
Drug development and management of patients
Future directions

CASES Reports


The CASES (Community Access via Scientific Engagement Strategies) reports yield a wealth of information about the community practice setting, on a US-regional basis. It is powered by our sister company Axess Oncology‘s network of physicians. CASES reports are written based on a series of regional meetings. Each CASES meeting features a nationally renowned key opinion leader, a moderator, and 8 to 12 high-decile community physicians. The program and content are developed by the key opinion leader and TRM Oncology, allowing inclusion of compelling questions in the discussion.

CASES reports
Provide a deep understanding of the regionally distinct market issues in the US that drive treatment decisions
Bridge the gap in information exchange between US community oncologists and industry
Promote understanding of current scientific knowledge and opinions among physicians

Oncology Insights Calendar

Learn more about the upcoming EPIC and CASES events and how you can benefit. Select the topic of your interest to see all upcoming events.

Click to filter by cancer type
  • All
  • Biosimilars
  • Breast Cancer
  • Colorectal Cancer
  • Gastrointestinal Cancer (GI)
  • Genitourinary Malignancies (GU)
  • Head and Neck Cancer
  • Leukemia
  • Lung Cancer
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • EPIC Congress Coverage: ASCO GI 2017
    Dr Axel Grothey

    January 21, 2017

    San Francisco, CA, US
    Request More Information
  • EPIC Congress Coverage: ASCO GU 2017
    Dr Daniel P. Petrylak

    February 18, 2017

    Orlando, FL, US
    Request More Information
  • EPIC: Breast Cancer in 2017 and Beyond
    Dr Mohammad Jahanzeb

    April 7 & 8, 2017

    Las Vegas, NV, US
  • EPIC: Gastrointestinal Malignancies (CRC, Gastric, Pancreatic, HCC) in 2017 and Beyond
    Dr Howard Hochster

    May 5 & 6, 2017

    Denver, CO, US
    Read More
  • EPIC Congress Coverage: ASCO 2017 (EMEA Perspective on Lung Cancer)
    Dr Nasser Hanna

    June 5, 2017

    Chicago, IL, US
  • EPIC Congress Coverage: ASCO 2017 (Focus on Multiple Myeloma)
    Dr Rafael Fonseca

    June 5, 2017

    Chicago, IL, US
    -
  • EPIC Congress Coverage: ASCO 2017 (Colorectal Cancer)
    Dr Axel Grothey

    June 6, 2017

    Chicago, IL, US
  • EPIC Congress Coverage: ASCO 2017 (Focus on Lung Cancer)
    Dr Corey Langer

    June 6, 2017

    Chicago, IL, US
    .
  • EPIC Congress Coverage: ASCO 2017 (Focus on Breast Cancer)
    Dr Mohammad Jahanzeb

    June 6, 2017

    Chicago, IL, US
  • EPIC: SCCHN in 2017 and Beyond
    Dr Walter J. Curran, Jr

    August 4 & 5, 2017

    Atlanta, GA, US
    Read More
  • EPIC: Multiple Myeloma in 2017 and Beyond
    Dr Rafael Fonseca

    August 18 & 19, 2017

    Scottsdale, AZ, US
    -
  • EPIC: Leukemia in 2017 and Beyond
    Dr Martin S. Tallman

    August 25 & 26, 2017

    Las Vegas, NV, US
    -
  • EPIC: Global Perspectives on Breast Cancer in 2017 and Beyond
    Dr Nadia Harbeck

    September 8, 2017

    Madrid, Spain
  • EPIC: Global Perspectives in Melanoma in 2017 and Beyond
    Dr Jeff Weber and Dr Alexander M. M. Eggermont

    September 10, 2017

    Madrid, Spain
    .
  • EPIC: Global Perspectives on Biosimilars in 2017 and Beyond
    Dr Matti S. Aapro

    September 10, 2017

    Madrid, Spain
  • EPIC: Global Perspectives on Lung Cancer in 2017 and Beyond
    Dr Enriqueta Felip and Dr Corey Langer

    October 18, 2017

    Yokohama, Japan
    .
  • EPIC: Lung Cancer in 2017 and Beyond
    Dr Corey Langer

    November 3 & 4, 2017

    New York City, NY, US
    -
  • EPIC Genitourinary Malignancies in 2017 and Beyond
    Dr Daniel P. Petrylak

    December 2 & 3, 2017

    Washington, DC, US
    Read More
  • EPIC Congress Coverage: ASH 2017 (Focus on Leukemia)
    Dr Martin S. Tallman

    December, 2017

    Atlanta, GA, US
  • EPIC Congress Coverage: ASH 2017 (Focus on NHL)
    Dr Brad Kahl

    December 11, 2017

    Atlanta, GA, US
    -
  • EPIC Congress Coverage: ASH 2017 (Focus on Multiple Myeloma)
    Dr Rafael Fonseca

    December, 2017

    Atlanta, GA, US
    -
  • EPIC Congress Coverage: SABCS 2017
    Dr Mohammad Jahanzeb

    December, 2017

    San Antonio, TX, US
  • GI Malignancies January 2017

    Latest Report
    GI Malignancies — EPIC Congress Coverage from ASCO GI – 2017 – Expert Perspective and Strategic Insights

    On January 21, 2017, TRM Oncology brought together scientists and clinical investigators with expertise in GI Malignancies. The goal of the meeting was to discuss the latest developments in risk stratification and predictive markers, as well as current and investigational therapies and how this research will affect clinical trial development and future treatment paradigms.

    Request Information red

    Oncology Insights – what our clients say

    “I appreciated the opportunity to attend such a well-managed program. It was interesting to see and hear the expert interacting with expert aspect of the experience. I enjoyed the opportunity to interact with oncologists within my geographical region and beyond.”

    Product Manager – Biotech company

    Kachnic_Lisa-copy

    “This was probably the best “state of the field” meeting that I have attended and I was delighted to have participated. Your staff and the accommodations and food were excellent”

    Lisa Kachnic, MD

    benson

    “Thanks. Well organized and good discussions of the critical issues”

    Al Benson, MD

    HallerDaniel

    “I think it was a great meeting, and I very much appreciated the time allowed for discussion”

    Dan Haller, MD